U.S., Oct. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07870226) titled 'Suprachoroidal Triamcinolone Acetonide Monotherapy in Treatment-naive Center Involving Diabetic Macular Edema' on Oct. 06.
Brief Summary: The goal of this clinical trial is to evaluate whether a single injection of suprachoroidal triamcinolone acetonide (SCTA) improves visual outcomes in patients with treatment-naive diabetic macular edema involving the center of the macula. The study will also evaluate the safety of SCTA by monitoring for possible side effects, including an increase in intraocular pressure and cataract progression.
Patients will be evaluated at the start of the study (baseline) and will receive one injection of SC...